Beijing: An HIV vaccine being developed by Chinese scientists will be given to 160 volunteers in a second-phase clinical trial, a scientist at the Chinese Center for Disease Control and Prevention said.
The candidate vaccine, DNA-rTV, relies on replication of the DNA of HIV to stimulate effective immunisation, according to Shao Yiming, a chief HIV researcher at the centre.
Already a subscriber? Log in.
Subscribe or renew your subscriptions to win prizes worth up to RM68,000!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
